HRT Financial’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
AI
HRT Financial's HAE Position: Q2 2026 in Review
HRT Financial sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 193,634 shares — an estimated $10.9M sold.
HRT Financial first reported a position in HAE in Q1 2019 and held it in 12 quarters. The position peaked at $10.9M in Q1 2026. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- HRT Financial reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
- HRT Financial sold 193,634 Haemonetics shares in Q2 2026, an estimated $10.9M.
- HRT Financial first reported a position in Haemonetics in Q1 2019 and held it in 12 quarters.
- HRT Financial's Haemonetics position peaked at $10.9M in Q1 2026.
- 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.